Haya Therapeutics lands $65m Series A

Sofinnova Partners and Earlybird Venture Capital led the round.

8 May 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Briefs